Loading...
XLONPHC
Market cap40mUSD
Aug 19, Last price  
8.93GBP
Name

Plant Health Care PLC

Chart & Performance

D1W1MN
XLON:PHC chart
P/E
—
P/S
363.65
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
14.03%
Rev. gr., 5y
6.63%
Revenues
11m
-4.77%
8,611,00010,223,00013,679,00018,295,00019,851,00016,678,0007,085,0007,853,0007,752,0007,455,0006,880,0007,508,0006,329,0007,685,0008,128,0006,436,0006,611,0008,432,00011,767,00011,206,000
Net income
-4m
L-57.82%
-2,946,000-3,050,000-3,028,000-5,424,000-4,219,000-1,331,000-7,559,000-5,141,000-6,573,000-6,881,000-6,130,000-7,720,000-11,217,000-5,454,000-7,692,000-3,684,000-3,224,000-6,304,000-9,483,000-4,000,000
CFO
-6m
L+115.55%
-3,506,000-2,957,000-6,981,000-3,327,000-3,202,000-7,452,000-3,118,000690,000-6,707,000-6,251,000-4,548,000-7,512,000-9,146,000-4,877,000-6,272,000-4,407,000-2,492,000-3,215,000-2,714,000-5,850,000
Earnings
May 29, 2025

Profile

Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the Americas, Mexico, and internationally. It offers products to enhance the yield and quality of crops, such as corn, soybeans, citrus, sugar cane, and rice, as well as fruits and vegetables. The company provides Harpin aß, a recombinant protein, which acts as a biostimulant to enhance the yield and quality of crops; and Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease. It also distributes third-party biological products. The company was founded in 1995 and is headquartered in Holly Springs, North Carolina.
URL
https://www.planthealthcare.com/
IPO date
Jul 06, 2004
Employees
56
Domiciled in
US
Incorporated in
GB

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
11,206
-4.77%
11,767
39.55%
8,432
27.55%
Cost of revenue
15,777
21,005
14,813
Unusual Expense (Income)
NOPBT
(4,571)
(9,238)
(6,381)
NOPBT Margin
Operating Taxes
489
36
(111)
Tax Rate
NOPAT
(5,060)
(9,274)
(6,270)
Net income
(4,000)
-57.82%
(9,483)
50.43%
(6,304)
95.53%
Dividends
Dividend yield
Proceeds from repurchase of equity
26
9,060
BB yield
-0.09%
-30.85%
Debt
Debt current
269
492
437
Long-term debt
935
1,036
1,584
Deferred revenue
Other long-term liabilities
Net debt
(907)
(4,128)
(7,065)
Cash flow
Cash from operating activities
(5,850)
(2,714)
(3,215)
CAPEX
(85)
(133)
(382)
Cash from investing activities
(635)
8,013
(5,352)
Cash from financing activities
2,910
(601)
8,622
FCF
(7,388)
(7,861)
(5,156)
Balance
Cash
2,111
5,656
9,162
Long term investments
(76)
Excess cash
1,551
5,068
8,664
Stockholders' equity
(93,509)
(91,169)
(85,698)
Invested Capital
104,259
101,665
101,095
ROIC
ROCE
EV
Common stock shares outstanding
325,587
305,149
292,204
Price
0.04
-62.58%
0.10
-1.89%
0.10
-24.72%
Market cap
12,014
-60.07%
30,088
2.46%
29,367
-10.31%
EV
11,107
25,960
23,105
EBITDA
(3,854)
(8,570)
(5,814)
EV/EBITDA
Interest
197
61
Interest/NOPBT